Brain edema : a valid endpoint for measuring hepatic encephalopathy?
dc.contributor.author | Bémeur, Chantal | |
dc.contributor.author | Cudalbu, Cristina | |
dc.contributor.author | Dam, Gitte | |
dc.contributor.author | Thrane, Alexander S. | |
dc.contributor.author | Cooper, Arthur J. L. | |
dc.contributor.author | Rose, Christopher | |
dc.date.accessioned | 2020-01-03T14:44:26Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2020-01-03T14:44:26Z | |
dc.date.issued | 2016-06 | |
dc.identifier.uri | http://hdl.handle.net/1866/22932 | |
dc.subject | Brain edema | fr |
dc.subject | Hepatic encephalopathy | fr |
dc.subject | Astrocyte | fr |
dc.subject | Magnetic resonance imaging | fr |
dc.subject | Neurobehavior | fr |
dc.title | Brain edema : a valid endpoint for measuring hepatic encephalopathy? | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de nutrition | fr |
dc.identifier.doi | 10.1007/s11011-016-9843-9 | |
dcterms.abstract | Hepatic encephalopathy (HE) is a major complication of liver failure/disease which frequently develops during the progression of end-stage liver disease. This metabolic neuropsychiatric syndrome involves a spectrum of symptoms, including cognition impairment, attention deficits and motor dysfunction which eventually can progress to coma and death. Pathologically, HE is characterized by swelling of the astrocytes which consequently leads to brain edema, a common feature found in patients with acute liver failure (ALF) as well as in cirrhotic patients suffering from HE. The pathogenic factors involved in the onset of astrocyte swelling and brain edema in HE are unresolved. However, the role of astrocyte swelling/brain edema in the development of HE remains ambiguous and therefore measuring brain edema as an endpoint to evaluate HE is questioned. The following review will determine the effect of astrocyte swelling and brain edema on neurological function, discuss the various possible techniques to measure brain edema and lastly to propose a number of neurobehavioral tests to evaluate HE. | fr |
dcterms.isPartOf | urn:ISSN:0885-7490 | fr |
dcterms.isPartOf | urn:ISSN:1573-7365 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Bémeur, C., Cudalbu, C., Dam, G., Thrane, A. S., Cooper, A. J. L., & Rose, C. F. (2016). Brain edema: A valid endpoint for measuring hepatic encephalopathy? Metabolic Brain Disease, 31(6), 12491258. https://doi.org/10.1007/s11011-016-9843-9 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Metabolic brain disease | |
oaire.citationVolume | 31 | |
oaire.citationIssue | 6 | |
oaire.citationStartPage | 1249 | |
oaire.citationEndPage | 1258 |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.